These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands. Ghosh AK; Schiltz G; Perali RS; Leshchenko S; Kay S; Walters DE; Koh Y; Maeda K; Mitsuya H Bioorg Med Chem Lett; 2006 Apr; 16(7):1869-73. PubMed ID: 16480871 [TBL] [Abstract][Full Text] [Related]
7. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains. Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395 [TBL] [Abstract][Full Text] [Related]
8. Oximinoarylsulfonamides as potent HIV protease inhibitors. Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine. Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931 [TBL] [Abstract][Full Text] [Related]
10. P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant viruses. Degoey DA; Grampovnik DJ; Chen HJ; Flosi WJ; Klein LL; Dekhtyar T; Stoll V; Mamo M; Molla A; Kempf DJ J Med Chem; 2011 Oct; 54(20):7094-104. PubMed ID: 21899332 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral property of allophenylnorstatine-based HIV protease inhibitors incorporating D-cysteine derivatives as P2/P3 moieties. Ami E; Nakahara K; Sato A; Nguyen JT; Hidaka K; Hamada Y; Nakatani S; Kimura T; Hayashi Y; Kiso Y Bioorg Med Chem Lett; 2007 Aug; 17(15):4213-7. PubMed ID: 17537628 [TBL] [Abstract][Full Text] [Related]
12. Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains. Miller JF; Furfine ES; Hanlon MH; Hazen RJ; Ray JA; Robinson L; Samano V; Spaltenstein A Bioorg Med Chem Lett; 2004 Feb; 14(4):959-63. PubMed ID: 15013001 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Randolph JT; Huang PP; Flosi WJ; DeGoey D; Klein LL; Yeung CM; Flentge C; Sun M; Zhao C; Dekhtyar T; Mo H; Colletti L; Kati W; Marsh KC; Molla A; Kempf DJ Bioorg Med Chem; 2006 Jun; 14(12):4035-46. PubMed ID: 16504523 [TBL] [Abstract][Full Text] [Related]
14. Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II). Hohlfeld K; Wegner JK; Kesteleyn B; Linclau B; Unge J J Med Chem; 2015 May; 58(9):4029-38. PubMed ID: 25897791 [TBL] [Abstract][Full Text] [Related]
15. Structural and kinetic analysis of pyrrolidine-based inhibitors of the drug-resistant Ile84Val mutant of HIV-1 protease. Böttcher J; Blum A; Heine A; Diederich WE; Klebe G J Mol Biol; 2008 Nov; 383(2):347-57. PubMed ID: 18692068 [TBL] [Abstract][Full Text] [Related]
16. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV. Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195 [TBL] [Abstract][Full Text] [Related]
18. Design, biologic evaluation, and SAR of novel pseudo-peptide incorporating benzheterocycles as HIV-1 protease inhibitors. He M; Zhang H; Yao X; Eckart M; Zuo E; Yang M Chem Biol Drug Des; 2010 Aug; 76(2):174-80. PubMed ID: 20572811 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains. Smith AB; Charnley AK; Harada H; Beiger JJ; Cantin LD; Kenesky CS; Hirschmann R; Munshi S; Olsen DB; Stahlhut MW; Schleif WA; Kuo LC Bioorg Med Chem Lett; 2006 Feb; 16(4):859-63. PubMed ID: 16298527 [TBL] [Abstract][Full Text] [Related]
20. PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study. Dandache S; Coburn CA; Oliveira M; Allison TJ; Holloway MK; Wu JJ; Stranix BR; Panchal C; Wainberg MA; Vacca JP J Med Virol; 2008 Dec; 80(12):2053-63. PubMed ID: 19040279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]